{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:30:37Z","timestamp":1789749037711,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR\u2009=\u20093.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.<\/jats:p>","DOI":"10.1038\/s41598-017-09386-9","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T14:33:15Z","timestamp":1502807595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-8314","authenticated-orcid":false,"given":"In\u00e9s","family":"G\u00f3mez-Acebo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Dierssen-Sotos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Fernandez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Palazuelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Aragon\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Casta\u00f1o-Vinyals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J.","family":"Jim\u00e9nez-Monle\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Ruiz-Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-8214","authenticated-orcid":false,"given":"Beatriz","family":"P\u00e9rez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Ruiz-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Alonso","family":"Molero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Poll\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolis","family":"Kogevinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"9386_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int.J.Cancer \n                           136, E359\u2013E386 (2015).","journal-title":"Int.J.Cancer"},{"key":"9386_CR2","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/cncr.20408","volume":"101","author":"DG Bostwick","year":"2004","unstructured":"Bostwick, D. G. et al. Human prostate cancer risk factors. Cancer \n                           101, 2371\u20132490 (2004).","journal-title":"Cancer"},{"key":"9386_CR3","first-page":"89","volume":"40","author":"DA Burks","year":"1992","unstructured":"Burks, D. A. & Littleton, R. H. The epidemiology of prostate cancer in black men. Henry Ford Hosp. Med. J. \n                           40, 89\u201392 (1992).","journal-title":"Henry Ford Hosp. Med. J."},{"key":"9386_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.urology.2003.10.013","volume":"62","author":"ED Crawford","year":"2003","unstructured":"Crawford, E. D. Epidemiology of prostate cancer. Urology \n                           62, 3\u201312 (2003).","journal-title":"Urology"},{"key":"9386_CR5","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2741\/1891","volume":"11","author":"AW Hsing","year":"2006","unstructured":"Hsing, A. W. & Chokkalingam, A. P. Prostate cancer epidemiology. Front. Biosci. J. Virtual Libr. \n                           11, 1388\u20131413 (2006).","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"9386_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.7326\/0003-4819-118-10-199305150-00007","volume":"118","author":"KJ Pienta","year":"1993","unstructured":"Pienta, K. J. & Esper, P. S. Risk factors for prostate cancer. Ann. Intern. Med. \n                           118, 793\u2013803 (1993).","journal-title":"Ann. Intern. Med."},{"key":"9386_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1464-410X.2004.04795.x","volume":"93","author":"PC Dagnelie","year":"2004","unstructured":"Dagnelie, P. C., Schuurman, A. G., Goldbohm, R. A. & Van den Brandt, P. A. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int. \n                           93, 1139\u20131150 (2004).","journal-title":"BJU Int."},{"key":"9386_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrc1389","volume":"4","author":"LN Kolonel","year":"2004","unstructured":"Kolonel, L. N., Altshuler, D. & Henderson, B. E. The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat. Rev. Cancer \n                           4, 519\u2013527 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"9386_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/oxfordjournals.epirev.a000798","volume":"23","author":"LNF Kolonel","year":"2001","unstructured":"Kolonel, L. N. F. meat, and prostate cancer. Epidemiol. Rev. \n                           23, 72\u201381 (2001).","journal-title":"Epidemiol. Rev."},{"key":"9386_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/02841860510029572","volume":"44","author":"A Wolk","year":"2005","unstructured":"Wolk, A. Diet, lifestyle and risk of prostate cancer. Acta Oncol. Stockh. Swed. \n                           44, 277\u2013281 (2005).","journal-title":"Acta Oncol. Stockh. Swed."},{"key":"9386_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/aja.2011.142","volume":"14","author":"KM Wilson","year":"2012","unstructured":"Wilson, K. M., Giovannucci, E. L. & Mucci, L. A. Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J. Androl. \n                           14, 365\u2013374 (2012).","journal-title":"Asian J. Androl."},{"key":"9386_CR12","unstructured":"World Cancer Research Fund International\/American Institute for Cancer Research Continuous Update Project Report. Diet, Nutrition, Physical Activity, and Prostate Cancer (2014)."},{"key":"9386_CR13","first-page":"61","volume":"69","author":"G Markozannes","year":"2016","unstructured":"Markozannes, G. et al. Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence. Eur. J. Cancer Oxf. Engl. 1990 \n                           69, 61\u201369 (2016).","journal-title":"Eur. J. Cancer Oxf. Engl. 1990"},{"key":"9386_CR14","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1158\/1055-9965.EPI-13-0568","volume":"23","author":"JB Hjelmborg","year":"2014","unstructured":"Hjelmborg, J. B. et al. The heritability of prostate cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. \n                           23, 2303\u20132310 (2014).","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"key":"9386_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. \n                           343, 78\u201385 (2000).","journal-title":"N. Engl. J. Med."},{"issue":"Spec No 1","key":"9386_CR16","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1093\/hmg\/ddh072","volume":"13","author":"DJ Schaid","year":"2004","unstructured":"Schaid, D. J. The complex genetic epidemiology of prostate cancer. Hum. Mol. Genet. \n                           13(Spec No 1), R103\u2013121 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"9386_CR17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/ejhg.2008.12","volume":"16","author":"KC Seng","year":"2008","unstructured":"Seng, K. C. & Seng, C. K. The success of the genome-wide association approach: a brief story of a long struggle. Eur. J. Hum. Genet. EJHG \n                           16, 554\u2013564 (2008).","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"9386_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrurol.2013.266","volume":"11","author":"R Eeles","year":"2014","unstructured":"Eeles, R. et al. The genetic epidemiology of prostate cancer and its clinical implications. Nat. Rev. Urol. \n                           11, 18\u201331 (2014).","journal-title":"Nat. Rev. Urol."},{"key":"9386_CR19","unstructured":"Eeles, R. A. et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat. Genet. 45, 385\u2013391, 391e1\u20132 (2013)."},{"key":"9386_CR20","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1158\/1055-9965.EPI-08-0317","volume":"17","author":"Z Kote-Jarai","year":"2008","unstructured":"Kote-Jarai, Z. et al. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. \n                           17, 2052\u20132061 (2008).","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"key":"9386_CR21","doi-asserted-by":"publisher","unstructured":"Castano-Vinyals, G. et al. Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. Gac.Sanit. doi:10.1016\/j.gaceta.2014.12.003 (2015).","DOI":"10.1016\/j.gaceta.2014.12.003"},{"key":"9386_CR22","unstructured":"ciberesp.qxp \u2212 03_Cuestionario-alimentario_09Nov09.pdf. Available at: http:\/\/www.mccspain.org\/wp-content\/uploads\/2016\/04\/03_Cuestionario-alimentario_09Nov09.pdf (Accessed: 23rd June 2017)."},{"key":"9386_CR23","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/S1470-2045(14)70211-6","volume":"15","author":"J Cuzick","year":"2014","unstructured":"Cuzick, J. et al. Prevention and Early Detection of Prostate Cancer. Lancet Oncol. \n                           15, e484\u2013e492 (2014).","journal-title":"Lancet Oncol."},{"key":"9386_CR24","doi-asserted-by":"publisher","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","volume":"32","author":"BE Ainsworth","year":"2000","unstructured":"Ainsworth, B. E. et al. Compendium of physical activities: an update of activity codes and MET intensities. Med. Sci. Sports Exerc. \n                           32, S498\u2013504 (2000).","journal-title":"Med. Sci. Sports Exerc."},{"key":"9386_CR25","unstructured":"WHO | What is Moderate-intensity and Vigorous-intensity Physical Activity? WHO Available at: http:\/\/www.who.int\/dietphysicalactivity\/physical_activity_intensity\/en\/ (Accessed: 5th May 2017)."},{"key":"9386_CR26","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 894, i\u2013xii, 1-253 (2000)."},{"key":"9386_CR27","unstructured":"Hindorff, L. et al. A Catalog of Published Genome-Wide Association Studies. www.genome.gov\/gwastudies Available at: https:\/\/www.genome.gov\/26525384\/catalog-of-published-genomewide-association-studies\/ (Accessed: 9th September 2016) (2015)."},{"key":"9386_CR28","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btn564","volume":"24","author":"AD Johnson","year":"2008","unstructured":"Johnson, A. D. et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics \n                           24, 2938\u20132939 (2008).","journal-title":"Bioinformatics"},{"key":"9386_CR29","unstructured":"SNAP P Search. Available at: http:\/\/archive.broadinstitute.org\/mpg\/snap\/ldsearch.php (Accessed: 7th February 2017)."},{"key":"9386_CR30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/aje\/kwm069","volume":"166","author":"R M\u00e5nsson","year":"2007","unstructured":"M\u00e5nsson, R., Joffe, M. M., Sun, W. & Hennessy, S. On the estimation and use of propensity scores in case-control and case-cohort studies. Am. J. Epidemiol. \n                           166, 332\u2013339 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"9386_CR31","doi-asserted-by":"publisher","unstructured":"Steyerberg, E. W. Clinical Prediction Models., doi:10.1007\/978-0-387-77244-8 (Springer New York, 2009).","DOI":"10.1007\/978-0-387-77244-8"},{"key":"9386_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00134-014-3227-6","volume":"40","author":"J Labar\u00e8re","year":"2014","unstructured":"Labar\u00e8re, J., Renaud, B., Bertrand, R. & Fine, M. J. How to derive and validate clinical prediction models for use in intensive care medicine. Intensive Care Med. \n                           40, 513\u2013527 (2014).","journal-title":"Intensive Care Med."},{"key":"9386_CR33","doi-asserted-by":"crossref","unstructured":"Pencina, M. J., D\u2019Agostino, R. B., D\u2019Agostino, R. B. & Vasan, R. S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 27, 157\u2013172; discussion 207\u2013212 (2008).","DOI":"10.1002\/sim.2929"},{"key":"9386_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina, M. J., D\u2019Agostino, R. B. & Steyerberg, E. W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med. \n                           30, 11\u201321 (2011).","journal-title":"Stat. Med."},{"key":"9386_CR35","unstructured":"GLOBOCAN 2012 age-specific table. Available at: http:\/\/globocan.iarc.fr\/old\/age-specific_table_r.asp?selection=182724&title=Spain&sex=1&type=0&stat=0&window=1&sort=0&submit=%C2%A0Execute (Accessed: 12th September 2016)."},{"key":"9386_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060083","volume":"8","author":"I Agalliu","year":"2013","unstructured":"Agalliu, I. et al. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction. PloS One \n                           8, e60083 (2013).","journal-title":"PloS One"},{"key":"9386_CR37","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/pros.23037","volume":"75","author":"R Szulkin","year":"2015","unstructured":"Szulkin, R. et al. Prediction of individual genetic risk to prostate cancer using a polygenic score: Polygenic Prostate Cancer Risk Score. The Prostate \n                           75, 1467\u20131474 (2015).","journal-title":"The Prostate"},{"key":"9386_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/caac.20096","volume":"61","author":"RA Smith","year":"2011","unstructured":"Smith, R. A. et al. Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA. Cancer J. Clin. \n                           61, 8\u201330 (2011).","journal-title":"CA. Cancer J. Clin."},{"key":"9386_CR39","first-page":"90","volume":"16","author":"S Loeb","year":"2014","unstructured":"Loeb, S. Prostate cancer screening: highlights from the 29th European association of urology congress stockholm, sweden, april 11-15, 2014. Rev. Urol. \n                           16, 90\u201391 (2014).","journal-title":"Rev. Urol."},{"key":"9386_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.acuro.2010.03.021","volume":"34","author":"PA Abrahamsson","year":"2010","unstructured":"Abrahamsson, P. A., Artibani, W., Chapple, C. R. & Wirth, M. [European Association of Urology. Position statement on screening for prostate cancer]. Actas Urol. Esp. \n                           34, 221\u2013222 (2010).","journal-title":"Actas Urol. Esp."},{"key":"9386_CR41","unstructured":"Final Update Summary: Prostate Cancer: Screening - US Preventive Services Task Force. Available at: https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/UpdateSummaryFinal\/prostate-cancer-screening (Accessed: 17th October 2016) (2016)."},{"key":"9386_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1046\/j.1464-410X.2003.04232.x","volume":"91","author":"LE Johns","year":"2003","unstructured":"Johns, L. E. & Houlston, R. S. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. \n                           91, 789\u2013794 (2003).","journal-title":"BJU Int."},{"key":"9386_CR43","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ijc.11466","volume":"107","author":"DW Bruner","year":"2003","unstructured":"Bruner, D. W., Moore, D., Parlanti, A., Dorgan, J. & Engstrom, P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int. J. Cancer \n                           107, 797\u2013803 (2003).","journal-title":"Int. J. Cancer"},{"key":"9386_CR44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1023\/A:1008823601897","volume":"9","author":"JM Chan","year":"1998","unstructured":"Chan, J. M. et al. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control CCC \n                           9, 559\u2013566 (1998).","journal-title":"Cancer Causes Control CCC"},{"key":"9386_CR45","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/ijc.23715","volume":"123","author":"EA Platz","year":"2008","unstructured":"Platz, E. A., Clinton, S. K. & Giovannucci, E. Association between plasma cholesterol and prostate cancer in the PSA era. Int. J. Cancer \n                           123, 1693\u20131698 (2008).","journal-title":"Int. J. Cancer"},{"key":"9386_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2891-z","volume":"16","author":"J Zhao","year":"2016","unstructured":"Zhao, J., Stockwell, T., Roemer, A. & Chikritzhs, T. Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysis. BMC Cancer \n                           16, 845 (2016).","journal-title":"BMC Cancer"},{"key":"9386_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E. & Ioannidis, J. P. A. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ \n                           350, g7607 (2015).","journal-title":"BMJ"},{"key":"9386_CR48","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/aje\/kwn190","volume":"168","author":"TJ Murtola","year":"2008","unstructured":"Murtola, T. J., Tammela, T. L. J., Lahtela, J. & Auvinen, A. Antidiabetic medication and prostate cancer risk: a population-based case-control study. Am. J. Epidemiol. \n                           168, 925\u2013931 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"9386_CR49","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.eururo.2014.04.027","volume":"66","author":"MA Preston","year":"2014","unstructured":"Preston, M. A. et al. Metformin use and prostate cancer risk. Eur. Urol. \n                           66, 1012\u20131020 (2014).","journal-title":"Eur. Urol."},{"key":"9386_CR50","first-page":"2831","volume":"50","author":"C-H Tseng","year":"2014","unstructured":"Tseng, C.-H. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus. Eur. J. Cancer Oxf. Engl. 1990 \n                           50, 2831\u20132837 (2014).","journal-title":"Eur. J. Cancer Oxf. Engl. 1990"},{"key":"9386_CR51","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.2337\/dc14-0584","volume":"37","author":"KK Tsilidis","year":"2014","unstructured":"Tsilidis, K. K. et al. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial. Diabetes Care \n                           37, 2522\u20132532 (2014).","journal-title":"Diabetes Care"},{"key":"9386_CR52","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ijc.30480","volume":"140","author":"C H\u00e4ggstr\u00f6m","year":"2017","unstructured":"H\u00e4ggstr\u00f6m, C. et al. Prospective study of Type 2 diabetes mellitus, anti\u2010diabetic drugs and risk of prostate cancer. Int. J. Cancer \n                           140, 611\u2013617 (2017).","journal-title":"Int. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09386-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09386-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:10:05Z","timestamp":1671786605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09386-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9386"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09386-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"assertion":[{"value":"15 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8994"}}